CNS vs FSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CNS

62.6
AI Score
VS
CNS Wins

FSK

53.8
AI Score

Investment Advisor Scores

CNS

63score
Recommendation
STRONG BUY

FSK

54score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS FSK Winner
Forward P/E 18.4502 7.9239 FSK
PEG Ratio 1.6881 3.2724 CNS
Revenue Growth 11.1% -27.1% CNS
Earnings Growth 0.0% 33.8% FSK
Tradestie Score 62.6/100 53.8/100 CNS
Profit Margin 28.2% -28.5% CNS
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY CNS

Relative Price Performance (Last 90 Days)

CNS 1M: -4.5% · 3M: -11.4% FSK 1M: -5.7% · 3M: -0.9%

Current Technical Phase

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $72.07

FSK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.6%), weak momentum, RSI 42

RSI (14): 41.8 · Price: $10.53

Fundamentals Snapshot

Metric CNS FSK
Market Cap — —
Forward P/E 19.3 7.0
Trailing P/E 21.6 —
Revenue (TTM) — —
Revenue Growth 0.1% -0.3%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% 0.7%
EPS 3.25 -1.34
Dividend Yield 0.04% 0.21%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.